These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 19080259

  • 1. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1975-9. PubMed ID: 19080259
    [Abstract] [Full Text] [Related]

  • 2. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
    Zhang D, Putti TC.
    Exp Cell Res; 2010 Dec 10; 316(20):3522-31. PubMed ID: 20833165
    [Abstract] [Full Text] [Related]

  • 3. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
    Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA.
    Cancer Res; 1993 Oct 01; 53(19):4443-8. PubMed ID: 8402609
    [Abstract] [Full Text] [Related]

  • 4. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
    Wang Z, Butt K, Wang L, Liu H.
    Nutr Cancer; 2007 Oct 01; 58(2):230-8. PubMed ID: 17640170
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 6. Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
    Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL.
    Cancer Res; 1992 Jul 01; 52(13):3648-54. PubMed ID: 1617638
    [Abstract] [Full Text] [Related]

  • 7. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb 01; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 8. Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis.
    Aroui S, Brahim S, Hamelin J, De Waard M, Bréard J, Kenani A.
    Apoptosis; 2009 Nov 01; 14(11):1352-65. PubMed ID: 19731037
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L, Menendez JA, Liu H, Lupu R.
    Differentiation; 2007 Nov 01; 75(9):819-30. PubMed ID: 17999741
    [Abstract] [Full Text] [Related]

  • 10. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ, Liu ZJ, Shimoi K, Zhu BT.
    Cancer Res; 2005 Jan 15; 65(2):387-93. PubMed ID: 15695378
    [Abstract] [Full Text] [Related]

  • 11. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
    Zoli W, Ulivi P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti L, Brigliadori G, Vannini I, Amadori D.
    Breast Cancer Res; 2005 Jan 15; 7(5):R681-9. PubMed ID: 16168113
    [Abstract] [Full Text] [Related]

  • 12. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R.
    Cancer Res; 2000 Apr 01; 60(7):2040-8. PubMed ID: 10766196
    [Abstract] [Full Text] [Related]

  • 13. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S, Brahim S, De Waard M, Bréard J, Kenani A.
    Cancer Lett; 2009 Nov 18; 285(1):28-38. PubMed ID: 19523755
    [Abstract] [Full Text] [Related]

  • 14. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 18; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 18; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 16. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT, Yu D, Hung MC.
    Oncogene; 1997 Aug 18; 15(8):953-60. PubMed ID: 9285690
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of flow cytometric assay for measurement of human intracellular heat shock protein 27.
    De AK, Strickland J.
    J Immunoassay Immunochem; 2007 Aug 18; 28(3):189-98. PubMed ID: 17613666
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA, Di X, Walker TD, Sawyer ST.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M, Wang J, Chen P, Reilly RM.
    Bioconjug Chem; 2006 Apr 01; 17(5):1280-7. PubMed ID: 16984139
    [Abstract] [Full Text] [Related]

  • 20. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
    Akbas SH, Timur M, Ozben T.
    J Surg Res; 2005 May 01; 125(1):49-55. PubMed ID: 15836850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.